Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Watch live as near-Earth asteroid Eros buzzes the Andromeda Galaxy on Nov. 30 (video) - 2Why home maintenance deserves a spot in the annual health and budget plans
- 3The most effective method to Use an Internet Showcasing Degree for Advanced Predominance
- 4Figure out How to Get the Best Open Record Rewards
- 510 Distinct Kinds of Chinese Neighborhood Specialty Hot Pot
- US FDA unveils new pathway to approve personalized therapies
- Cyprus: War-related tourism concerns and climate change efforts
- 'Stranger Things' character guide: The nerds, the newcomers and the rest of the Season 5 cast
- Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application
- Several Israelis attempt to cross into Gaza, escorted back to Israel by IDF
- Israeli forces kill one person in series of attacks on southern Lebanon
- Inflammatory Merz remarks on migrants' violence against women slammed
- Robert Pattinson claims he's a pathological liar. What 'The Drama' star has said about his 'shtick'
- Exhaustive Experiences into Prudent Senior Living in the UK
